Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, January 28, 2025, inter alia; 1. To consider, approve, finalize the issue of warrants and price of warrants convertible into equity shares / or equity shares to be issued on preferential basis in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations). 2. To consider, approve, finalize, the proposal of fund raising by way of equity shares through rights issue in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations) as permitted under applicable law, subject to such regulatory/statutory approvals as may be required. 3. Any other matter with the permission of chair.